News
News
- Nike's Q4 revenues at $12.2B, down 1% YoY
06/27/2022 / 22:16 - TeleTrader - Unilever shares rise after Nelson Peltz joins BoD
05/31/2022 / 10:59 - TeleTrader - Cytovia Therapeutics’ Leadership to Present at Upcoming Conferences
03/29/2022 / 16:56 - GlobeNewswire - Statera Biopharma, Inc. to Report Fourth Quarter and Full Year 2021 Financial Results on March 31, 2022
03/28/2022 / 13:30 - GlobeNewswire - Statera Biopharma Announces Closing of $5.7 Million Underwritten Public Offering
03/24/2022 / 22:28 - GlobeNewswire - AIM ImmunoTech Announces Abstract Entitled, Negative Impact of Paclitaxel on Human Breast Tumor Microenvironment and Its Reversal by the Combination of Interferon-α with TLR3 Agonist Rintatolimod, (Ampligen®), Accepted for Poster Presentation by Roswell Park Comprehensive Cancer Center at the AACR 2022 Annual Meeting
03/24/2022 / 15:10 - GlobeNewswire - Protara Therapeutics Doses First Patient in ADVANCED-1 Phase 1 Study of TARA-002 in Non-Muscle Invasive Bladder Cancer
03/24/2022 / 13:00 - GlobeNewswire - Vanqua Bio to Present at the Stifel 2022 CNS Day Conference
03/24/2022 / 12:30 - GlobeNewswire - Affimed to Report Full Year 2021 Financial Results & Corporate Update on March 31, 2022
03/24/2022 / 11:30 - GlobeNewswire - Elicio Therapeutics Presents Preclinical Data on its Amphiphile-CpG Adjuvant at the STING & TLR-Targeting Therapies Summit 2022 Digital Event
03/23/2022 / 20:30 - GlobeNewswire
Real-time